Background
We aimed to ascertain if Gastrokine 1 mRNA in the sera of patients with gastric cancer might be an informative biomarker for the disease.
Conclusions
Our preliminary results did not confirm GKN1 as a potential biomarker for gastric cancer.
Results
Analysis of GKN1 mRNA in serum samples from healthy individuals (n = 23) and from patients with diagnosis of gastric cancer (n = 16), performed by using absolute quantification based on standard curve method, did not show any significative statistical difference between the two unpaired group of individuals. Conclusions: Our preliminary results did not confirm GKN1 as a potential biomarker for gastric cancer.